Search
-
What Worries the World - April 2022
Inflation is now the top global worry for the first time, with 26 out of 27 countries recording an increase in concern over the last month.
-
What Do Online Consumers Really Think of Electric Cars in 2022
Social data reveals how consumers feel about new Electric Vehicle (EV) models
-
Presidential election in France: Emmanuel Macron re-elected but abstention hits record high
Rejection and a weariness of voting to keep candidates out rather than in is the prevailing sentiment among abstainers and voters who cast a blank or invalid ballot, with little support for the plans of the two candidates among those who did cast a ballot. This survey conducted by Ipsos and Sopra Steria for france-tv and radiofrance on the motivations for voting shows that neither Marine Le Pen nor Emmanuel Macron truly succeeded in convincing those beyond their electoral base of the first round.
-
London maintains top “city brand” ranking from 2020 to 2022. Paris rises to second and Sydney lands in third.
London preserves its spot as the world’s most admired city in the 2022 edition of the Anholt-Ipsos City Brands Index. Paris, Sydney, New York, and Rome round out the top-5, but there has been some movement in the bottom half of the top-10 cities:
-
Short hits of retail truth
This video series explores how the shopper landscape is changing and the new forms of commerce which are emerging.
-
Train your creative muscle to spark brand growth… join the Misfits webinar
Join us for an exclusive marathon webinar journey with Ipsos' Creative Excellence Team!
-
Flash Eurobarometer: Women in times of COVID-19
Marking International Women’s Day 2022 on 8 March, the European Parliament, Directorate General for Communication, commissioned Ipsos European Public Affairs to conduct a new Flash Eurobarometer survey to gather women's opinions on the impact of the COVID-19 pandemic.
-
Covid-19: Expectations and vaccination
Majorities in each of 30 countries believe we will never fully stop the spread of COVID, but views on vaccination mandates vary widely.
-
A Year in Oncology: A review of 2021 drug approvals in US, Europe and Japan
Whilst the global COVID-19 pandemic continued throughout 2021, new oncology drug and indication approvals maintained momentum across the US, Europe and Japan. These included continued roll-out and label expansions of Immuno-Oncology (I-O) therapies, along with treatments approved in Japan ahead of other global regions.